162 related articles for article (PubMed ID: 21402888)
1. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility.
Harris SJ; Parry RV; Foster JG; Blunt MD; Wang A; Marelli-Berg F; Westwick J; Ward SG
J Immunol; 2011 Apr; 186(8):4936-45. PubMed ID: 21402888
[TBL] [Abstract][Full Text] [Related]
2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
3. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
Wain CM; Westwick J; Ward SG
Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
[TBL] [Abstract][Full Text] [Related]
4. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
5. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
[TBL] [Abstract][Full Text] [Related]
6. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.
Dyson JM; O'Malley CJ; Becanovic J; Munday AD; Berndt MC; Coghill ID; Nandurkar HH; Ooms LM; Mitchell CA
J Cell Biol; 2001 Dec; 155(6):1065-79. PubMed ID: 11739414
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
[TBL] [Abstract][Full Text] [Related]
8. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
[TBL] [Abstract][Full Text] [Related]
9. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading.
Koch A; Mancini A; El Bounkari O; Tamura T
Oncogene; 2005 May; 24(21):3436-47. PubMed ID: 15735664
[TBL] [Abstract][Full Text] [Related]
10. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
11. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production.
Gabhann JN; Higgs R; Brennan K; Thomas W; Damen JE; Ben Larbi N; Krystal G; Jefferies CA
J Immunol; 2010 Mar; 184(5):2314-20. PubMed ID: 20100929
[TBL] [Abstract][Full Text] [Related]
12. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
13. [The mechanism for SHIP gene to induce the apoptosis of human leukemia cell line K562.].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L; Yang JC
Sheng Li Xue Bao; 2009 Apr; 61(2):146-54. PubMed ID: 19377826
[TBL] [Abstract][Full Text] [Related]
14. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T
PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositides in the regulation of actin cortex and cell migration.
Tsujita K; Itoh T
Biochim Biophys Acta; 2015 Jun; 1851(6):824-31. PubMed ID: 25449647
[TBL] [Abstract][Full Text] [Related]
16. The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells.
Mancini A; Koch A; Wilms R; Tamura T
Oncogene; 2002 Feb; 21(10):1477-84. PubMed ID: 11896575
[TBL] [Abstract][Full Text] [Related]
17. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
[TBL] [Abstract][Full Text] [Related]
18. Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival.
Chaigne-Delalande B; Anies G; Kramer I; Genot E
Oncogene; 2008 Mar; 27(13):1876-85. PubMed ID: 17906692
[TBL] [Abstract][Full Text] [Related]
19. The SH2-domain-containing inositol 5-phosphatase (SHIP) limits the motility of neutrophils and their recruitment to wounds in zebrafish.
Lam PY; Yoo SK; Green JM; Huttenlocher A
J Cell Sci; 2012 Nov; 125(Pt 21):4973-8. PubMed ID: 22946052
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
